The use of combined conjoint approaches to improve market share predictions

Within the pharmaceutical prescription sector, just like many other markets, maintaining competitive advantage has become increasingly difficult.
  

The Use Of Combined Conjoint Approaches To Improve Market Share Predictions

Allan Bowditch Gustavo GurrieriandBeverley HenryMartin Hamblin GfK

Background

Given the everincreasing pressure on pharmaceutical companies to provide an attractive return on investment to shareholders, the higher costs involved in bringing a product to market (estimated to be in the region of $800 million), and increased downward pressure on prices, there is a greater need to prioritise the potential offered by a range of new product opportunities. New product opportunities arise from:

  • A company's own research and development (R&D) efforts
  • Inlicensing opportunities
  • Joint marketing...

Not a subscriber?

Schedule your live demo with our team today

WARC helps you to plan, create and deliver more effective marketing

  • Prove your case and back-up your idea

  • Get expert guidance on strategic challenges

  • Tackle current and emerging marketing themes

We’re long-term subscribers to WARC and it’s a tool we use extensively. We use it to source case studies and best practice for the purposes of internal training, as well as for putting persuasive cases to clients. In compiling a recent case for long-term, sustained investment in brand, we were able to support key marketing principles with numerous case studies sourced from WARC. It helped bring what could have been a relatively dry deck to life with recognisable brand successes from across a broad number of categories. It’s incredibly efficient to have such a wealth of insight in one place.

Insights Team
Bray Leino

You’re in good company

We work with 80% of Forbes' most valuable brands* and 80% of the world's top top-of-the-class agencies.

* Top 10 brands